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Apicomplexan actin polymerization 
depends on nucleation
Esa-Pekka Kumpula1, Isa Pires  1, Devaki Lasiwa1, Henni Piirainen1, Ulrich Bergmann1,  
Juha Vahokoski1,2 & Inari Kursula  1,2
Filamentous actin is critical for apicomplexan motility and host cell invasion. Yet, parasite actin 
filaments are short and unstable. Their kinetic characterization has been hampered by the lack of 
robust quantitative methods. Using a modified labeling method, we carried out thorough biochemical 
characterization of malaria parasite actin. In contrast to the isodesmic polymerization mechanism 
suggested for Toxoplasma gondii actin, Plasmodium falciparum actin I polymerizes via the classical 
nucleation-elongation pathway, with kinetics similar to canonical actins. A high fragmentation rate, 
governed by weak lateral contacts within the filament, is likely the main reason for the short filament 
length. At steady state, Plasmodium actin is present in equal amounts of short filaments and dimers, 
with a small proportion of monomers, representing the apparent critical concentration of ~0.1 µM. The 
dimers polymerize but do not serve as nuclei. Our work enhances understanding of actin evolution and 
the mechanistic details of parasite motility, serving as a basis for exploring parasite actin and actin 
nucleators as drug targets against malaria and other apicomplexan parasitic diseases.
Actin is an extensively studied filament-forming cytoskeletal protein with roles ranging from endocytosis to 
vesicle trafficking and cell motility. Actin polymerizes by a nucleation-elongation mechanism, meaning that the 
process is split into a thermodynamically unfavorable nucleation phase, a linear elongation phase, and a plateau 
phase, where the rates of polymerization and depolymerization are equal. The rate-limiting step is nucleation, 
during which small nuclei, likely trimers1–3, form spontaneously and initiate the directional rapid polymeriza-
tion from the fast-growing barbed end of the filament. The formation of nuclei and subsequent polymerization 
proceed only above a certain critical concentration (Cc) of actin, which in standard assay conditions is ~0.1 µM4.
Plasmodium spp. are unicellular protozoan parasites of the apicomplexan phylum and cause one of the glob-
ally most devastating human diseases: malaria. In the motile stages of the Plasmodium life cycle, the parasite 
moves by an active process called gliding, a form of motility unique to Apicomplexa. Gliding motility and host cell 
invasion rely on an unconventional actin-myosin motor5. The major actin isoform I, expressed also in the motile 
and invasive stages of the parasite, is one of the most divergent actin orthologs known6–8. Plasmodium falciparum 
actin I (PfActI) has a comparably low sequence identity to canonical actins (82% compared to human actins, 79% 
compared to Saccharomyces cerevisiae actin) and forms only short, transient filaments in vitro6,7,9. Recently, it was 
proposed that actin of Toxoplasma gondii, a related apicomplexan parasite, polymerizes in an isodesmic man-
ner that is not dependent on nucleation10. The isodesmic mechanism is characterized by a constant free-energy 
change at all stages of filament formation and exhibits therefore no lag phase and no Cc for polymerization11. 
Furthermore, the short length of apicomplexan actin filaments has been linked to unusually fast turnover12.
In Plasmodium, actin dynamics are regulated by a compact set of 10–15 actin-binding proteins5. In vitro char-
acterization of these has been mainly based on interactions with canonical actins, due to the lack of biochemical 
means for measuring parasite actin polymerization kinetics reliably. Many of the most accurate methods available 
for analyzing actin kinetics in vitro rely on fluorescent labels. Conventional protocols of actin labeling employ 
cycles of polymerization and depolymerization to obtain a polymerization-competent pool of labeled actin. 
While this purification by biological activity increases the quality of the labeled protein preparation, the amount 
of sample and time consumed for the process is incompatible with the properties of apicomplexan actins6,7. We 
present here a simple, fast, and generally applicable protocol for labeling Plasmodium actin I with N-(1-pyrene)
iodoacetamide (hereafter pyrene), and use fluorescence spectroscopy together with dynamic light scattering 
(DLS), native polyacrylamide gel electrophoresis (PAGE), and ultracentrifugation to analyze the biochemical 
properties of this so far kinetically uncharacterized actin.
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Results
Polymerized PfActI is present in three different states of assembly at the steady state. To 
investigate the polymerization of PfActI, we first applied a high relative centrifugal force of 434,500 g in an attempt 
to pellet all forms of the short filaments. Even at these forces, PfActI pelleted less efficiently than skeletal muscle 
α-actin (70% compared to 99%; Fig. 1A,B and Supplementary Fig. S1) and exhibited higher standard deviations 
between batches (10.8% compared to 1.5%). Notably, approximately half of PfActI in the supernatant fraction 
could be re-pelleted 6 h after the initial ultracentrifugation step (Fig. 1C). This implies that the material in the 
supernatant is polymerization competent and is in line with the notion that the average filament length is con-
centration independent13.
As a substantial fraction of PfActI did not pellet during ultracentrifugation, we employed dynamic light scat-
tering (DLS) to measure the size distribution of PfActI in polymerized samples. Polymerized PfActI showed a 
rough distribution into two populations with apparent hydrodynamic radii of 4.2 and 18 nm with mass percent-
age contributions of 35% and 65%, respectively. In terms of size, one can compare these to the hydrodynamic 
radius of α-actin in the G-state (2.7 nm, Fig. 1D) to infer that the size of the smaller population is, on average, 
larger than a monomer. Hydrodynamic radii of α-actin monomers as well as lateral and longitudinal dimers, 
constructed from high resolution filament models (PDB entry 3J8A14) and modeled using HYDROPRO15, are 
3.4, 4.4, and 4.6 nm, respectively, placing the smaller population in the monomer-dimer domain. We also meas-
ured the size distribution of different oligomeric species of PfActI in the supernatant fraction after centrifugation 
at 434,500 g. We found a marked decrease in the mass contribution of the larger peak from 65% to 11%, but no 
change in the hydrodynamic radius of either peak (Fig. 1D). We also analyzed the samples at a lower centrifugal 
force of 100,000 g, where only 60% of PfActI was present in the pellet fraction (Fig. 1A,B). The supernatant frac-
tion showed peaks in DLS at hydrodynamic radii of 10.5 and 53.6 nm, with 77% and 23% of total mass, respec-
tively (Fig. 1D).
To confirm our observations in DLS measurements, we used native PAGE, which can resolve oligomers at least 
up to 12 units7. We prepared samples of polymerized PfActI at 25 µM concentration with and without ultracen-
trifugation at 434,500 g and analyzed them in running conditions with a matched ADP to ATP concentration ratio 
and 0.1 mM MgCl2 (Fig. 1E). In these conditions and without ultracentrifugation, 43% of PfActI appears poly-
meric, while the rest appears as a dimer band and an extremely weak monomer band (Supplementary Fig. S1). 
Ultracentrifugation removes the polymeric material but retains the dimer and monomer bands (Supplementary 
Fig. S1).
Collectively, these results show that PfActI is present as three distinct populations in a polymerized sample at 
the steady state: a lower molecular weight population with an average hydrodynamic radius of 4.2 nm, comprising 
monomers and dimers, and a higher molecular weight population at 18 nm. Furthermore, due to the abundance 
of oligomers too small to sediment even at high centrifugal forces, ultracentrifugation is not the method of choice 
for determining the Cc of apicomplexan actins.
PfActI exhibits a critical concentration similar to canonical actins. We next determined, whether 
PfActI polymerizes in an isodesmic manner, as suggested for T. gondii actin10, or rather depends on a Cc like 
canonical actins. Indeed, when we analyzed the ultracentrifugation results of PfActI at different concentrations, 
as described before for T. gondii actin10, the data showed an absence of a plateau in the supernatant fraction 
(Supplementary Fig. S1), which could be interpreted as a lack of a Cc. The x-intercept of a linear fit of the pel-
let fraction, used in some studies16 as an indicator of a Cc from these plots, exhibited values ranging from 5 to 
100 nM in identical conditions. Thus, we decided to use a more sensitive and reliable fluorescence spectroscopic 
method17 requiring pyrene-labeled actin. As labeling PfActI with pyrene at the Cys374 position was unsuccessful 
using established protocols, we modified the protocol to be applicable to parasite actins. Three essential modifica-
tions were necessary for labeling PfActI: (i) the removal of polymerization-depolymerization cycling, (ii) the use 
of substoichiometric concentrations of pyrene, and (iii) the use of very short reaction times. These modifications 
enabled a sufficient degree of labeling for several types of classical actin assays.
We verified the labeling of PfActI by liquid chromatography-coupled mass spectrometry (LC-MS) and 
compared the results to α-actin labeled with traditional approaches and our method (Supplementary Fig. S2). 
As another control, we analyzed α-actin labeled using both methods in a spontaneous polymerization assay 
(Supplementary Fig. S2). LC-MS indicated that α-actin was labeled at one site per monomer with both methods 
and PfActI at one site per monomer with the new method. The kinetic profiles of α-actin were different between 
the two methods, with the traditional labeling producing twice as fast overall polymerization compared to the 
new method and a different curve shape in the nucleation phase. Removing residual unreacted reactants by 
small-scale desalting did not change the results (Supplementary Fig. S2). A possible explanation for the different 
behavior is that the polymerization-depolymerization cycling in the classical method removes any monomers 
that may be inactivated during the labeling procedure. Another possibility is the formation of a small number 
of nucleating oligomers also in α-actin during the longer time required for the traditional labeling method. To 
allow direct comparison between the two different actins, we have used α-actin labeled with our method in all 
experiments.
The Cc of PfActI at steady state could be determined after polymerization for 16 h at 20 °C at different starting 
concentrations. A linear increase in fluorescence signal could be seen, starting at around 0.1 µM and extending to 
5 µM, which was the highest concentration tested (Fig. 2A). Linear fits for the points below and above 0.1 µM were 
performed, and the Cc was determined as the x-coordinate of the intercept of these lines. A Cc of 0.11 ± 0.03 µM 
was found (mean ± standard deviation, n = 3). In the same conditions, α-actin exhibited a Cc of 0.06 ± 0.03 µM, 
which is slightly lower but statistically indistinguishable from the value obtained for PfActI (p = 0.18, Student’s 
t-test). Immediately after ultracentrifugation of pyrene-labeled polymerized PfActI, there was still fluorescence 
signal in the supernatant, confirming the presence of PfActI in non-monomeric, yet non-pelleting assemblies 
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(Supplementary Fig. S2). Additionally, densitometry analysis of native PAGE (Fig. 1E, Supplementary Fig. S1) 
showed that 0.43% of total band intensity is present in the very weak monomer band. This translates into 0.11 µM 
in the 25 µM sample, which notably is identical to the Cc obtained at steady state. The rest of the band intensity 
was divided roughly equally between dimers (56.2%, 14 µM) and polymers (43.4%, 11 µM). The monomer and 
Figure 1. Assembly states of polymerized PfActI. (A) Representative gel of a standard pelleting assay of PfActI 
and α-actin at a total protein concentration of 4 µM, separated at 434,500 g (top) or 100,000 g (bottom) at 20 °C 
for 1 h. S and P stand for supernatant and pellet, respectively. Molecular weight standard sizes (in kDa) are 
indicated on the left. (B) Pelleting assay results of PfActI at 434,500 g (n = 12), at 100,000 g (n = 3), and α-actin 
at 434,500 g (n = 8), expressed as % of total protein in each fraction. Relative centrifugal forces have been 
indicated above each bar. (C) Two sequential pelleting assays (UC1 and UC2) of 10 µM PfActI, separated by 
6 h of incubation at 22 °C, spun at 434,500 g for 1 h (n = 3). (D) DLS profiles of α-actin in the monomeric state, 
polymerized PfActI, and polymerized PfActI after ultracentrifugation at 100,000 g and 434,500 g. (E) Native 
PAGE of 25 µM polymerized PfActI before (left) and after (right) ultracentrifugation at 434,500 g in running 
conditions with sample-matched ATP:ADP ratio and 0.1 mM MgCl2. The sample after ultracentrifugation 
represents the supernatant. Letters on the left indicate monomers (m), dimers (d), or polymers (p), based on 
relative mobility values obtained before7. Images in (E) have been lightly contrast-adjusted. Error bars in (B) 
and (C) represent standard deviation, ***p < 0.001, **p < 0.05, ns: not significant, Student’s t-test.
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dimer bands are visible after ultracentrifugation, but the polymers and higher oligomers are not (Supplementary 
Fig. S1). Interestingly, PfActI incubated for 16 h at 20 °C in a classical non-polymerizing buffer also displayed a Cc 
of 0.06 ± 0.03 µM (mean ± standard deviation, n = 3) (Fig. 2B). This is in line with our previous observation that 
PfActI forms oligomers, likely upon ATP hydrolysis, in G-buffer conditions7.
Spontaneous polymerization of PfActI is slow, yet depolymerization is fast. After the discov-
ery of a Cc for polymerization of PfActI, we decided to study its polymerization kinetics. However, spontane-
ous nucleation7 at the conditions used during purification and assays seemed initially to hinder recording of 
polymerization curves. A serendipitous discovery that relatively high concentrations of ammonium acetate could 
slow down the oligomerization of PfActI in vitro, as shown by DLS and native PAGE (Supplementary Fig. S3), 
led to a change in our initial protocol. Ammonium acetate also considerably slowed down α-actin nucleation 
(Supplementary Fig. S3). Inclusion of 0.3 M ammonium acetate in the final PfActI sample and removing it only 
immediately before the start of the measurement enabled us to record kinetic curves reproducibly (Fig. 3A). Still, 
the lag phase for PfActI polymerization was not as pronounced as for α-actin (Fig. 3B) and disappeared in the 
higher concentrations.
A critical kinetic parameter to determine for any actin is the elongation rate constant. As PfActI can 
co-polymerize with α-actin6 we determined elongation rates of PfActI in the presence of 0.5 µM polymerized 
α-actin over a range of monomer concentrations (Fig. 3C). The resulting curves were hyperbolic, and initial rates 
were determined and fitted against the monomeric PfActI concentration (Fig. 3E). Compared to similar data 
from α-actin (Fig. 3D,F), the curves of PfActI contained two distinct phases in the first few minutes, while those 
of α-actin contained only one. The slopes from the initial part (first 2 min) are significantly different (p < 0.01) 
between the two actins, while the slopes from the stable part (1–10 min) are statistically indistinguishable (Table 
1). Notably, the estimations for Cc (x-intercept) and dissociation rate constant (y-intercept) are unreliable as 
exhibited by their large error estimates and sometimes incorrect signs for both α-actin and PfActI (Table 1). 
Combining the results from steady-state critical concentration and the slope of the curves in Fig. 3E,F, we can 
calculate a corresponding relative k−*. The resulting values are 0.05 ± 0.02 s−1 for PfActI and 0.03 ± 0.02 s−1 for 
α-actin (Table 1).
To assess nucleation of α-actin by PfActI filaments, we determined the initial rate of polymerization of pyrene 
labeled α-actin using α-actin filament seeds, three concentrations of polymerized PfActI, and the supernatant of 
ultracentrifuged PfActI filaments (Fig. 4, Supplementary Fig. S4). The results showed positive, but weaker nuclea-
tion of α-actin by PfActI filaments and a disappearance of nucleation activity upon removal of pelleting material 
by ultracentrifugation.
We next assayed the depolymerization of PfActI to determine, whether diluting the sample below the Cc 
would induce depolymerization. This was, indeed, the case, and PfActI depolymerized substantially faster than 
α-actin with half-times of 74 and 376 s, respectively (Fig. 5A). We then determined, whether the depolymeriza-
tion of PfActI could be modulated by including recombinantly expressed Plasmodium actin-binding proteins. P. 
falciparum actin depolymerizing factor 1 (PfADF1) and P. berghei ADF2 (PbADF2) both increased the rate of 
depolymerization in a concentration-dependent manner (Fig. 5B,C). Depolymerization of gelsolin-capped fila-
ments showed identical depolymerization curves to uncapped PfActI, even though we have previously shown that 
gelsolin segment 1 binds PfActI monomers7. PfADF1 affected both gelsolin-capped and uncapped filaments iden-
tically (Supplementary Fig. S4). Similarly to the parasite ADFs and human profilin18, high concentrations of P. fal-
ciparum profilin (PfPfn) increased the depolymerization rate as well as the final fluorescence level (Fig. 5D). These 
results strongly indicate that the folding of recombinant PfActI produced in baculovirus-infected insect cells is 
correct, as the biological interaction between PfActI and Plasmodium ADFs and profilin can be reconstituted in 
Figure 2. Critical concentration of PfActI determined using pyrene fluorescence. (A) Cc plot in F-buffer shows 
a critical concentration at 0.13 µM (indicated by the vertical dotted line). Points below 0.2 µM are excluded 
for clarity but shown in the inset. Inset: zoomed view of the lower concentrations. Axes of the inset are the 
same as in the full image. (B) Cc plot in G-buffer shows a critical concentration of 0.04 µM in this experiment 
(indicated by the vertical dotted line). Error bars representing standard deviation are hidden under the symbols. 
a.u. = arbitrary units, not comparable between (A) and (B). To analyze the data, a two-line fit was performed, as 
described in Materials and Methods.
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vitro. This, together with our previous functional characterization and high-resolution crystal structures of both 
Plasmodium actin isoforms7,19,20 and the high-resolution structure of PfActI in its F-form21 should remove any 
doubts about the folding state of recombinantly expressed PfActI raised by recent speculations22.
Treadmilling assays revealed that, while treadmilling of α-actin could be accelerated by PfADF1 as expected23, 
PfActI treadmilling appears unaffected by the inclusion of either PfADF1 or PbADF2 (Supplementary Fig. S4). In 
addition, the overall profile is different for the actins alone. This implies differences either in the effect of ADFs on 
PfActI treadmilling or in the way PfActI releases its bound nucleotide.
In conclusion, the PfActI elongation rate constant (k+) is statistically indistinguishable from α-actin, and 
its net depolymerization rate, as well as the apparent dissociation rate constant (k−*), is larger. This should lead 
to a higher Cc for PfActI than α-actin. However, although we do see a small difference in this direction in our 
Figure 3. Polymerization kinetics of PfActI and α-actin as determined using pyrene fluorescence. (A) 
Spontaneous polymerization curves of PfActI induced by the addition of F-buffer components. (B) Spontaneous 
polymerization curves of α-actin as in (A). (C) Nucleated polymerization curves of PfActI seeded with 
0.5 µM filamentous α-actin. (D) Nucleated polymerization curves of α-actin seeded with 0.5 µM filamentous 
α-actin. (E) Plot of elongation rates of PfActI from (C) vs. PfActI monomer concentration at the initial phase 
(0–120 s) and at the stable phase (60–600 s). (F) As in (E), but with α-actin. Pyrene labeling was performed 
using the fast labeling method for both PfActI and α-actin in all experiments. Note the different time scales 
in (A–D). a.u. = arbitrary units, scaled to achieve comparable rates between the two actins using plateau-level 
fluorescence.
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experimental conditions, this difference is not statistically significant. In conditions nucleated by α-actin fila-
ments, PfActI polymerizes faster initially but slows down to α-actin levels over a time span of a few minutes. 
Despite the faster depolymerization and shorter filament length, treadmilling of PfActI seems unexpectedly slow 
and, moreover, is not affected by the presence of otherwise active ADFs.
Discussion
Established labeling protocols for actin rely on labeling in the filamentous state, combined with one or more 
cycles of polymerization and depolymerization17,24. However, sensitive actin samples may be either incompletely 
polymerizing, available in low quantities, unstable over time, or all of the above, as is the case for apicomplexan 
actins. For these cases, a fast labeling method requiring no polymerization-depolymerization cycling and low 
sample quantities is essential. To address these issues, we developed a method that allowed us to characterize the 
properties of PfActI that has so far eluded detailed kinetic characterization. In stark contrast to what has been 
reported for T. gondii actin based on sedimentation by ultracentrifugation10, the fluorescence spectroscopic assay 
shows that PfActI exhibits a Cc for polymerization at ~0.1 µM, which is similar to the behavior of canonical actins. 
A similar or slightly lower Cc in G-buffer is in line with our earlier observation that both PfActI and PbActII oli-
gomerize in G-buffer over time and upon ATP hydrolysis7. The concomitant pyrene fluorescence signal increase 
upon the formation of these oligomers confirms that these oligomers are not an artefact of the native PAGE assay. 
Above the Cc, a major part of PfActI is split roughly equally to polymeric and dimeric components. After removal 
of the polymeric component by ultracentrifugation, the remaining component could not nucleate α-actin polym-
erization, demonstrating that the dimers cannot serve as nuclei. This is in agreement with reports on α-actin that 
propose the nucleus to be a trimer or tetramer1–3,25. Furthermore, plots of fluorescence vs. PfActI concentration 
(Supplementary Fig. S2) indicated that polymers disappear below the Cc.
PfActI filaments have been proposed to be highly dynamic, which implies fast treadmilling and, thus, fast on 
and off rates26. In contrast, we show that the elongation rate of α-actin-seeded PfActI relative to α-actin is sta-
tistically indistinguishable, which is in line with evidence that the elongation rate constant is diffusion-limited27. 
The initial fast phase of the nucleated polymerization - a 2.8-fold increase in slope compared to α-actin – could 
be explained by rapid formation of non-nucleating dimers and their subsequent incorporation into the filaments 
in the initial stages. Another possible scenario could stem from the heterologous interactions of α-actin barbed 
ends with PfActI monomer pointed ends, which could induce long-range changes in the filament conformation. 
PfActI α-actin
Nucleated polymerization (NP)
Initial Stable Initial Stable
k+ 1.56 ± 0.26* 0.50 ± 0.16 0.56 ± 0.16* 0.50 ± 0.10
Cc (µM) 0.00 ± 0.06 −0.02 ± 0.12 −0.04 ± 0.11 0.04 ± 0.07
k− −0.01 ± 0.10 0.01 ± 0.06 0.02 ± 0.06 −0.02 ± 0.03
Steady state (SS)
Cc (µM) 0.11 ± 0.03 0.06 ± 0.03
k−† 0.05 ± 0.02 0.03 ± 0.02
Table 1. Relative kinetic parameters of PfActI and α-actin. All values reported as mean ± standard deviation 
(PfActI: n = 5 in NP, n = 3 in SS, α-actin: n = 3 in both NP and SS). *p = 0.01 (two-tailed Student’s t-test) 
†Relative k− calculated using steady state Cc and the relative elongation rate constant (k+) from the stable phase 
of the nucleated polymerization assays.
Figure 4. Nucleation of α-actin polymerization by PfActI filaments. 1 µM pyrene-labeled α-actin monomers 
were polymerized in the presence of 0.5 µM polymerized α-actin, the supernatant from a polymerized PfActI 
sample after ultracentrifugation at 434,500 g as well as 0.5 µM, 2.5 µM, and 6.25 µM polymerized PfActI. A linear 
fit of the first 2 min was performed on the resulting curves (Supplementary Fig. S4) and the slopes compared. 
Ultracentrifugation removes nucleating material from polymerized PfActI samples, and the nucleation 
efficiency of polymerized PfActI is lower towards α-actin than that of α-actin itself. Error bars represent 
standard deviation (n = 3). (a.u. = arbitrary units).
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However, it seems implausible that this alone could be responsible for an increase of the observed magnitude. 
In any case, the enhancement of overall polymerization rates by introduction of nuclei to PfActI supports the 
nucleation-elongation mechanism. Conversely, PfActI also nucleates α-actin polymerization. Taking into account 
that only 70% of PfActI is in a polymeric form results in an estimated 2.6-fold lower nucleation efficiency com-
pared to α-actin. Combined, these results imply that interactions between α-actin barbed ends and PfActI mono-
mers are favorable, while those of PfActI barbed ends and α-actin monomers are unfavorable. This is in line with 
many of the residue-level changes in PfActI being located at the pointed-end interface7. We assume that pointed 
ends of the nuclei or the low concentration of monomers in the nucleating solutions in these experiments do not 
contribute significantly to the observed rates.
Although not functioning as nuclei, the PfActI dimers are polymerization competent. There are two possi-
bilities for the structural arrangement that pertain to what happens in a re-equilibrating supernatant fraction 
of PfActI: either the dimers are arranged in a conformation that facilitates polymerization directly or in a con-
formation that does not. In both cases, polymerization via dissociation of the dimers is possible. In the former 
case, annealing of dimers is also an option. As estimates of annealing rate constants for short filaments, of which 
dimers are an extreme case28–30, are comparable to the association rate constants at the barbed end, resolving this 
difference with simple kinetic assays is not straightforward. Considering that simulations suggest very high Kd 
values for dimer formation of α-actin1,3,31,32, the presence of a large pool of dimers in polymerized PfActI is inter-
esting and probably reflects the weaker lateral interactions in the filament. The most probable route for nucleus 
formation is the formation of a longitudinal dimer, followed by the addition of a monomer to start the second 
protofilament1. Since interprotofilament contacts in PfActI filaments are among the more diverged from α-actin 
filaments7 and ostensibly facilitate weaker interactions, it is conceivable that the dimers are longitudinal rather 
than lateral, and the addition of the third protomer, i.e. nucleus formation is the rate limiting step, as in canonical 
actins. In fact, one would thus expect PfActI to be even more dependent on nucleation promoting factors com-
pared to canonical actins.
Figure 5. Dilution-induced depolymerization curves of PfActI. (A) Comparison of PfActI and α-actin, 
depolymerized by dilution from 5 µM to 50 nM. Half-times of depolymerization were 74 ± 4.3 s for PfActI 
(n = 3) and 376 ± 71 s for α-actin (n = 2). Values represent mean ± standard deviation. The rates are normalized 
based on a single-phase exponential decay fit of the data. (B) PfActI depolymerized in the presence of three 
concentrations of PfADF1 in the diluting buffer. For clarity, curves are moved to the right in increments 
of 20 s, leaving the curve with 0.5 µM PfADF1 at its initial place. (C) PfActI depolymerization as in (B), 
but supplemented with PbADF2 instead of PfADF1. (D) PfActI depolymerization in the presence of high 
concentrations of PfPfn in the dilution buffer. (a.u. = arbitrary units).
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Contrary to the polymerization rate, the overall depolymerization rate of PfActI is faster compared to α-actin. 
However, dilution-induced depolymerization curves are difficult to quantify, due to several overlapping decays 
contributing to the measured curves33, so only qualitative information can be extracted. Assuming a single-phase 
decay, the obtained half-times correspond to apparent rate constants of 9.3 × 10–3 s−1 for PfActI and 1.8 × 10−3 s−1 
for α-actin. Adjusting by filament concentration determined from experiments in Figs 3, 4 and Supplementary 
Fig. S4 (α-actin34) or by assuming 100 nm filament length (PfActI) yields depolymerization rate constants of 
7.2 s−1 and 0.4 s−1, respectively. On the other hand, the k−* (Table 1) of PfActI is 2-fold larger than that of α-actin. 
We hypothesize that this discrepancy can be explained by a significant reduction of k− of ADP-PfActI from the 
barbed end, which is the main determinant of depolymerization rate in our experimental conditions, but would 
not affect the kinetics of polymerizing ATP-PfActI. As an alternative explanation, substantial increases in filament 
length (1–2 µm) would be expected in order to raise the depolymerization rate constant to α-actin levels. Such 
long filaments of PfActI in the absence of stabilizing agents have not been documented.
PfADF1, PbADF2 and PfPfn seem to modulate the depolymerization of PfActI as expected. However, we 
cannot completely rule out fluorescence quenching upon filament binding as a cause for the observed increase 
in the apparent depolymerization rate. Yet, the increase in the final fluorescence level is rather indicative of 
monomer binding35. Capping PfActI filaments with human plasma gelsolin (Supplementary Fig. S4) did not 
change the effect of PfADF1, implying that the depolymerization activity of PfADF1 is located at the pointed end. 
Surprisingly, the apparent treadmilling rate of PfActI was not faster than that of α-actin, and unlike the depolym-
erization rate, the treadmilling rate was not affected by Plasmodium ADFs. This could be related to how PfActI 
interacts with ε-ATP, since we were previously unable to exchange the nucleotide of PfActI to non-hydrolyzable 
analogues7. On the other hand, the initial signals from α-actin and PfActI samples were similar, indicating incor-
poration of ε-ATP. PfADF1 increases the nucleotide exchange rate of bovine β-actin36, measured in the direction 
Ca-ATP to ε-ATP. Here, the direction is Mg-ε-ADP to ATP, which is a crucial difference. ADFs preferentially bind 
ADP-actin23, and the nucleotide exchange effect could be modulated by the nucleotide state and the bound cation.
Concluding Remarks
In contrast to the isodesmic model suggested for the polymerization of T. gondii actin, we show that Plasmodium 
falciparum actin I polymerizes via the classical nucleation-elongation pathway. Taking into account the high 
sequence similarity between different apicomplexan actins and that the sedimentation-based methods are insen-
sitive to short oligomers, it seems likely that also other parasitic actins follow a similar nucleation-elongation 
polymerization pathway. This is also supported by recent in vivo work on T. gondii actin37,38. Since the kinetic 
parameters of polymerization as well as treadmilling rates were similar in PfActI and α-actin, the observed dif-
ferences in filament lengths would have to be due to changes in the fragmentation-annealing equilibrium. This 
is a defining factor for the steady-state filament lengths of α-actin13,39. Both processes are governed in PfActI by 
weaker interprotofilament contacts, which also likely explain the large dimer content at steady state. Thus, tar-
geting the divergent lateral contacts may turn out to be a way to specifically inhibit parasite actin polymerization. 
Our data also suggest that nucleation is of particular importance for parasite actin-related processes. The small 
number of actin regulators, in particular only the formins present as nucleating factors, should make this a vul-
nerable step in the parasite life cycle. Thus, parasite formins, being also highly diverged from their opisthokont 
homologues, should be considered as drug targets against malaria and other apicomplexan parasitic diseases.
Materials and Methods
Protein expression and purification. Recombinant PfActI, PfADF1, PbADF2, and PfPfn were purified 
using standard protocols, as described before40 and in the Supplementary Methods. Skeletal muscle α-actin was 
purified from pig muscle as described before40,41.
Pelleting assays. Unlabeled actin was polymerized overnight at 22 °C by adding F-buffer to a final polym-
erizing condition of 50 mM KCl, 4 mM MgCl2, 1 mM EGTA, followed by ultracentrifugation at 434,500 g at 20 °C 
for 1 h. The supernatant was removed and either prepared directly or after acetone precipitation for SDS-PAGE. 
The pellet from ultracentrifugation was resuspended directly into SDS-PAGE sample buffer in an identical vol-
ume to the corresponding supernatant sample. The samples were separated using SDS-PAGE in Tris-glycine 
buffer. When a large linear response range was desired (as in Supplementary Fig. S1), gels were stained by SYPRO 
Orange gel stain (Invitrogen) in 7.5% acetic acid overnight, washed for 30 s with 7.5% acetic acid, then transferred 
to ultrapure water and imaged using a BioRad ChemiDoc XRS+ gel imager. Alternatively, gels were stained 
with colloidal Coomassie (Thermo Scientific, 24620). The intensities of the corresponding supernatant and pellet 
bands were extracted using the program ImageLab (BioRad) and compared to their sum to get a fraction of total 
actin in each fraction and multiplying it by the total concentration of actin in the sample.
When determining the oligomeric state of actin in the supernatant fraction, samples of overnight polymerized 
actin were spun at either 100,000 g or 434,500 g for 1 h at 20 °C. The supernatant fraction was separated and ana-
lyzed by DLS, native PAGE and SDS-PAGE – the latter together with the pellet sample.
Dynamic light scattering and native gel electrophoresis. DLS was measured using a Wyatt DynaPro 
PlateReader-II instrument in a 384-well plate (Corning, 3540). Long acquisition times (up to 60 s) were probed 
to record signals from longer filaments. Mass percentage contribution to individual peaks in the regularization 
graph was estimated using the coils model of the DYNAMICS program (version 7.1.7.16). The constraints for 
fitting were loosened by one from the resolution slider in the regularization graph options to resolve the peaks.
Native PAGE was performed essentially as described7. However, the ratio of ATP to ADP was determined 
from the steady-state samples prior to native PAGE using the ADP-Glo™ kit (Promega), and a corresponding 
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mixture of ATP and ADP was used in the running buffer (see Supplementary Methods). Gels were stained with 
SYPRO Orange to improve sensitivity and with Coomassie brilliant blue in Supplementary Fig. S3.
Critical concentration determination. Pyrene-labeled PfActI was polymerized by adding F-buffer, dilut-
ing to a series of concentrations, and incubating overnight at 22 °C. The fluorescence was then measured from 
triplicate samples using a fluorescence plate reader with identical optical settings as in the polymerization assays 
(see below). The sample volume was 200 µl. The results were fitted using a two-line equation:
= + − ×y y (x x ) kcross cross
where xcross and ycross are shared x and y coordinates for the two lines at their intersection and k is the slope. The 
fitting was performed using 1/Y2 weighting in GraphPad Prism 5.04.
Actin polymerization assays. Polymerization assays were carried out in a TECAN M1000 Pro instrument 
using 96-well plates (Greiner 655077), an excitation wavelength of 365 nm (9 nm bandpass) and an emission 
wavelength of 407 nm (20 nm bandpass). The gain was set manually to 100 for all measurements and the number 
of flashes to 5 per measurement. Polymerization was initiated with F-buffer in a total reaction volume of 150 µl. 
Before the start of the measurement, a 2 s orbital mixing step was performed at 258 rpm (2.5 mm amplitude).
Nucleated polymerization assays were carried out using freshly labeled actin without dilution by unlabeled 
actin. Nuclei were prepared essentially as described before34, whereby an unlabeled filament stock of 5 µM was 
diluted to 0.75 µM in 1.5X F-buffer and vortexed for 0.5 s. These diluted filaments were immediately used for 
assays. A 100-µl aliquot of this mixture was carefully transferred into measurement wells before adding 50 µl of 
labeled actin monomers at three times the final concentration. Polymerization curves were recorded using the 
settings above. Nucleated polymerization assays with PfActI nuclei were prepared as above, using a constant 
1.0 µM labeled α-actin monomer concentration. PfActI samples were pelleted at 434,500 g and used as nuclei 
immediately.
Depolymerization assays. Dilution-induced depolymerization assays were performed using 30% 
pyrene-labeled actins. 5 µM actins were polymerized overnight as described above. Depolymerization was 
induced by diluting a 2-µl sample rapidly 100-fold in F-buffer containing ADFs or profilin, when applicable, and 
the measurement conducted as above for the polymerization assays, with the exception of not including a mixing 
step in the beginning to reduce dead times to a minimum.
Treadmilling assays. Treadmilling assays were prepared essentially as described17 with the exception of 
using similar actin buffers and polymerizing conditions as used in our other experiments and polymerizing 
PfActI for 2 h. Briefly, DOWEX 1 × 8 200–400 (Sigma Aldrich) was used to remove free ATP from the actin 
solution, an excess of 1,N6-ethenoadenosine 5′-triphosphate (ε-ATP, Jena Biosciences) was supplied for an over-
night incubation on ice, followed by a removal of ε-ATP by DOWEX and adding a trace amount of ε-ATP. The 
Ca-ε-ATP:actin was then polymerized and the polymerized sample was treated with ATP to chase out the bound 
ε-ATP while the fluorescence was monitored over time. The fluorescence signal was read using an excitation 
wavelength of 350 nm (9 nm bandpass) and an emission of 410 nm (20 nm bandpass) using the same instrument 
as above.
Data availability. The datasets generated and analyzed during the current study are available from the cor-
responding author upon reasonable request.
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